• Home
  • Search Results

Research Studies

UNC-Chapel Hill Division of Hematology

33 studies match your search
Coming Soon

A Comparator Study of a Tasso device to traditional venous blood sampling methods for CBC in patients with leukemia, lymphoma, or other blood cell disorders

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Leukemia, Lymphoma)
Coming Soon

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

This study is being done to determine whether older adult patients diagnosed with mantle cell lymphoma require continuous treatment with the study drug zanubrutinib once remission has been retained.

Age & Gender
  • 60 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Coming Soon

An Acute Leukemia Study

The purpose of this study is to find out if treatment with the study drug, Bexmarilimab, along with standard of care can help with your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Chronic Myelogenous Leukemia Study

Have you been diagnosed with Leukemia and looking for another option? Do you have Chronic Myelogenous Leukemia? In this study, we want to learn more about how effective the study drug (asciminib) works for patients with CML-CP who have had one prior therapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Understanding Outcome Differences in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL)

If you or your child has been diagnosed with acute lymphoblastic leukemia (ALL), you or they might be able to take part in a research study. This study aims to understand why there are differences in outcomes in adolescents and young adults treated for ALL.

Age & Gender
  • 15 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Leukemia)
  • Child and Teen Health
Open

A Study of Investigational Medication for Relapsed or Refractory Multiple Myeloma

Do you have relapsed or refractory multiple myeloma? Have you received at least one type of treatment? If so, you may be able to take part in a research study looking at the the safety of giving an investigational medication to patients with multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

Essential Thrombocythemia (ET) medication study.

Do you have essential thrombocythemia (ET)? If you need to start therapy or your currently therapy is not controlling your ET, you may be able to take part in this research study to find out if a new drug can help normalize your blood count.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Coming Soon

Blood Clotting Risk in Blood Cancer Study

People with chronic blood cancers called myeloproliferative neoplasms (MPN) have a significantly increased risk of stroke, heart attack, and blood clots compared to the general population. This blood clot risk is only slightly reduced by current treatment. In this study, we are exploring blood tests that may help us learn why people with MPN clot and how current MPN treatment affects those blood tests. This is a blood draw-only study.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

Our HHT Registry

Are you an adult with Hereditary Hemorrhageic Telangiectasia (HHT) ? Information about people living with this rare genetic disease HHT is urgently needed. The purpose of this study is to collect a bank of information about people living with HHT to better understand HHT, the symptoms and complications it causes and how the disease impacts people's lives.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Rare Diseases
By physician referral or invitation only

Testing the Usability of a Patient-Centered Tool

We are developing a computer-based tool for people who have cancers of the blood, bone marrow, and lymph nodes. This tool will help us understand what is most important to patients when it comes to the results of their treatment. We are looking for healthy volunteers (those without cancer) to help us test the usability of this tool.

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research